BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6825113)

  • 1. Accumulation of a blood group antigen precursor in oral premalignant lesions.
    Dabelsteen E; Vedtofte P; Hakomori S; Young WW
    Cancer Res; 1983 Mar; 43(3):1451-4. PubMed ID: 6825113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies in the diagnosis of epithelial premalignant lesions.
    Dabelsteen E; Graem N; Hakomori S; Young WW
    Bull Cancer; 1983; 70(2):127-31. PubMed ID: 6871487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
    Skovlund VR
    APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial isoantigens A, B and H in oral carcinomas.
    Gupta YN; Gupta S; Singh IJ; Khanna NN; Agarwal MK
    Ear Nose Throat J; 1985 May; 64(5):239-42. PubMed ID: 3996275
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of the specificities of human blood group H gene-specified alpha 1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between alpha 1,2-L-fucosylation of Gal and alpha 1,6-L-fucosylation of asparagine-linked GlcNAc.
    Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
    Biochemistry; 1996 Jul; 35(27):8914-24. PubMed ID: 8688427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.
    Dabelsteen E; Clausen H; Holmstrup P; Reibel J
    APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathology of the oral mucosa. Oral immune system--inflammatory reactions--tumor-"marker"--virus identification].
    Löning T
    Veroff Pathol; 1984; 121():1-178. PubMed ID: 6322469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood group ABO-related antigens in fetal and normal adult bladder urothelium. Immunohistochemical study of type 2 chain structures with a panel of mouse monoclonal antibodies.
    Orntoft TF; Wolf H; Clausen H; Hakomori S; Dabelsteen E
    Lab Invest; 1988 May; 58(5):576-83. PubMed ID: 3285099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
    Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
    Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa.
    Martínez-Lara I; González-Moles MA; Ruiz-Avila I; Bravo M; Ramos MC; Fernández-Martínez JA
    Acta Stomatol Belg; 1996 Mar; 93(1):29-32. PubMed ID: 8986050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of blood group antigens A, B, H, Lewis a, Lewis b, in malignant lesions of the uterine cervix].
    Sasagawa T; Inoue M; Shimizu C; Shimizu H; Saito J; Ueda G; Tanizawa O; Nakayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):345-52. PubMed ID: 2834474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the glycosylation pattern of histo-blood group antigens in benign, premalignant and malignant laryngeal epithelial lesions.
    Stenersen TC; Dabelsteen E
    APMIS Suppl; 1992; 27():139-48. PubMed ID: 1520523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte populations in premalignant lesions and cancer of the oral cavity.
    Pillai MR; Balaram P; Abraham T; Nair MK
    Neoplasma; 1987; 34(4):469-79. PubMed ID: 3498910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Ca 1 monoclonal antibody in distinguishing oral squamous cell carcinoma from non-malignant or premalignant oral lesions.
    Masouredis CM; Green TL; Greenspan JS
    J Oral Pathol; 1987 Jul; 16(6):307-9. PubMed ID: 3119804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of blood group antigens in premalignant and malignant lesions of the human exocervix.
    Stubbe Teglbjaerg C; Norrild B; Dabelsteen E
    Acta Pathol Microbiol Immunol Scand A; 1985 May; 93(3):149-51. PubMed ID: 4013740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO (H) blood group antigen expression in gastric mucosa.
    Matias-Guiu X; Guix M
    Pathol Res Pract; 1988 Aug; 183(4):476-80. PubMed ID: 3054827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive rise of c fos expression from premalignant to malignant lesions of oral cavity.
    Sachdev R; Mandal AK; Singh I; Agarwal AK
    Med Oral Patol Oral Cir Bucal; 2008 Nov; 13(11):E683-6. PubMed ID: 18978706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.